The anti-cancer effect of CD109 is further supported by our results showing that overexpression of CD109 in A431 cancer cells effectively attenuates the basal and TGF-β-induced EMT responses and suppresses migration and invasion of these cells.These findings demonstrate that CD109 mediates the anti-cancer effects of hBM-MSC-CM such as inhibition of EMT, migration and invasion, are consistent with our previous report that CD109 is a strong inhibitor of TGF-β signaling [19–21, 23]. The gene discussed is CD109; the disease is cancer.